Company profile: Citagenix
1.1 - Company Overview
Company description
- Provider of bone grafts (allografts, synthetics, xenografts); membranes (non-resorbable and resorbable); surgical essentials (screws, tacks, titanium meshes); devices (Penguin accessories, devices, pegs); Regen accessories (single-use bone delivery syringes, wound dressings); and sutures (non-resorbable and resorbable) for medical procedures and surgical use.
Products and services
- Surgical Essentials: Citagenix supplies titanium meshes, screws, and tacks for medical use, delivering a focused assortment of metallic components and fasteners
- Membranes: Citagenix delivers resorbable and non-resorbable membranes used in medical procedures, offering two membrane categories for clinician selection
- Bone Grafts: Citagenix offers medical-grade bone grafts, including allografts, synthetics, and xenografts for medical applications, spanning diverse material classes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Citagenix
BioStructures
HQ: United States
Website
- Description: Provider of bioresorbable bone graft product platforms and medical device solutions, including Signafuse bioactive bone graft putty, Interface bioactive bone graft, Osteomatrix mineralized collagen scaffold, Osteoplus bone graft composite, Exponent demineralized bone matrix, and Purebone.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioStructures company profile →
Aspen Medical Products
HQ: United States
Website
- Description: Provider of upper and lower spinal orthopedic bracing products for post-trauma stabilization, motion restriction, pain therapy, and promoting natural alignment. Offers cervical solutions such as Aspen and Vista Collars, options for thoracic and lumbosacral ailments, and conducts upper and lower spine research and biomechanical analysis to inform clinical decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aspen Medical Products company profile →
MiRus
HQ: United States
Website
- Description: Provider of innovative solutions for the treatment of spinal and orthopedic degeneration and deformities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MiRus company profile →
Nextremity
HQ: United States
Website
- Description: Provider of precise, innovative, procedure-ready, sterile implant systems for foot and ankle surgery, including Stratum anatomic locking plate systems for osteotomies, fractures, mal- and non-unions, fusions and ankle arthrodesis, and InCore three-part constructs for internal fixation and arthrodesis of First and Lesser Tarsometatarsal and Subtalar joints.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nextremity company profile →
Biotech International
HQ: France
Website
- Description: Provider of dental and orthopaedic implants, operating as both manufacturer and exclusive distributor. Founded in 1987 in France, Biotech International ensures products meet European standards for manufacturing, traceability, safety, labelling and packaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotech International company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Citagenix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Citagenix
2.2 - Growth funds investing in similar companies to Citagenix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Citagenix
4.2 - Public trading comparable groups for Citagenix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →